Thomas L. Kempner

Filings by Thomas L. Kempner span 6 companies, the busiest being Dyax Corp, Intersections Inc and Igene Biotechnology Inc. The record holds 126 filings, for trades running from 28 February 2002 to 17 March 2018.

Both buying and selling appear: 17 purchases worth €5.3M, against 47 sales worth €21.2M. Taken together, the sales exceed the purchases by €15.9M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant and 33 option exercises.

The median purchase comes to €14k.

Most recently, on 19 March 2018, the filings show an option exercise in Intersections Inc. The clock since the last published purchase (24 November 2015) now reads 3,986 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.